WUXI XDC News

Pharmaceutical Federation (2268.HK): Significantly increasing the upper limit demand for raw material procurement agreements and continuing high order growth

民生證券Apr 29 00:00

Pharmaceutical Federation (02268.HK): Strong profitability highlights the advantages of continuous expansion of integration

廣發證券Apr 7 00:00

Pharmaceutical Federation (02268.HK): Performance doubled, the ADC circuit wave has arrived

天風證券Apr 4 00:00

Pharmaceutical Federation (02268.HK): Rapid growth in performance, integrated CRDMO platform empowers the entire ADC production and development process

國信證券Apr 3 10:31

Pharmaceutical Federation (02268.HK): Steadily Promoting Global Production Capacity Construction, Abundant Ongoing Orders, Ensuring High Growth

開源證券Apr 2 15:51

Pharmaceutical Federation (2268.HK): Performance is in line with expectations, XDCCRDMO leaders are growing rapidly

中信建投證券Mar 29 00:00

Pharmaceutical Federation (2268.HK): Revenue and profit are growing rapidly, and on-hand orders are abundant. It is expected that multiple PPQ projects will be completed in 2024, and the long-term development of the one-stop conjugated drug CRDMO is optimi

海通國際Mar 28 19:41

Pharmaceutical Federation (02268.HK): Performance exceeds expectations, global production capacity construction continues to advance

國聯證券Mar 27 19:41

Pharmaceutical Federation (02268.HK): 2023 results exceeded expectations and raised 2024 revenue guidelines

中金公司Mar 27 14:11

BOC International: Maintaining the Target Price of HK$42 for the “Buy” Rating of Pharmaceutical Plus (02268)

Zhitong FinanceMar 27 09:46

Pharmaceutical Federation (02268.HK): The ADC circuit is booming, and ADCCRDMO's leading performance is growing strongly

東吳證券Mar 27 07:26

Pharmaceutical Federation (2268.HK) 2023 Annual Report Review: One-stop Platform Empowers ADC New Drug Development to Accelerate Global Production Capacity Expansion

民生證券Mar 26 20:31

Pharmaceutical Federation (2268.HK): FY23 performance exceeds expectations, technological advance+capacity expansion continues to drive high future growth

交銀國際Mar 26 00:00

Yao Ming Joint Federation (02268.HK): Strong sails full of momentum, Yao Ming combined to prosper

太平洋證券Mar 19 00:00

Pharmaceutical Federation (2268.HK): Global bioconjugated drug CRDMO service leader

開源證券Mar 6 00:00

Pharmaceutical Alliance (02268.HK): Forward-looking layout to create an integrated advantage platform for rapid growth

廣發證券Feb 25 00:00

Tianfeng Securities: The global market share of the “Buy” rating of Shouyu Pharmaceutical (02268) is expected to continue to increase

Zhitong FinanceFeb 19 15:21

Pharmaceutical Federation (02268.HK): CRDMO Empowers Global Pharmaceutical Companies The ADC Track Wave Has Arrived

天風證券Feb 15 00:00

Pharmaceutical Federation (02268.HK): a rapidly developing one-stop ADC CRDMO leader

國聯證券Feb 6 19:06

Pharmaceutical Federation (2268.HK): Performance growth exceeds expectations, leading global ADC outsourcing companies are growing rapidly

民生證券Feb 2 15:56